New Flexibilities Available to Healthcare and Life Sciences Companies Under Loosened HHS-OIG Advisory Opinion Procedures

Jan 18, 2022

Trendspotting 2022: On the Pulse of Life Sciences

Jan 18, 2022

Proposed Changes to the California Proposition 65 Short-Form Warning Label

Jan 18, 2022

Key Physician Payment Sunshine Act Updates Published by CMS

Jan 18, 2022

We are excited to announce that Nirogy Therapeutics, Inc. has named a new CEO, industry leader, Simon C. Pedder, Ph.D.

Jan 12, 2022

Publication Finds that Modernization of U.S. Newborn Screening System is Necessary, Calls for Change

Jan 06, 2022

Posted by Orchard Therapeutics

CATO SMS AND PHARM-OLAM MERGE TO CREATE GLOBAL BIOPHARMACEUTICAL SERVICES LEADER

Jan 05, 2022

Posted by Allucent